PMID: 11927665Apr 3, 2002Paper

A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?

The Journal of Physiology
Manjula WeerapuraTerence E Hébert

Abstract

Although it has been suggested that coexpression of minK related peptide (MiRP1) is required for reconstitution of native rapid delayed-rectifier current (I(Kr)) by human ether-a-go-go related gene (HERG), currents resulting from HERG (I(HERG)) and HERG plus MiRP1 expression have not been directly compared with native I(Kr). We compared the pharmacological and selected biophysical properties of I(HERG) with and without MiRP1 coexpression in Chinese hamster ovary (CHO) cells with those of guinea-pig I(Kr) under comparable conditions. Comparisons were also made with HERG expressed in Xenopus oocytes. MiRP1 coexpression significantly accelerated I(HERG) deactivation at potentials negative to the reversal potential, but did not affect more physiologically relevant deactivation of outward I(HERG), which remained slower than that of I(Kr). MiRP1 shifted I(HERG) activation voltage dependence in the hyperpolarizing direction, whereas I(Kr) activated at voltages more positive than I(HERG). There were major discrepancies between the sensitivity to quinidine, E-4031 and dofetilide of I(HERG) in Xenopus oocytes compared to I(Kr), which were not substantially affected by coexpression with MiRP1. On the other hand, the pharmacological sensit...Continue Reading

References

Feb 22, 2000·The Journal of Biological Chemistry·A L PondJ M Nerbonne
Jun 6, 2000·Current Biology : CB·J CuiT V McDonald
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·F SestiS A Goldstein
Mar 22, 2002·Pflügers Archiv : European journal of physiology·Manjula WeerapuraStanley Nattel

❮ Previous
Next ❯

Citations

May 11, 2007·Archives of Pharmacal Research·Su-Hyun JoHan Choe
Nov 24, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Noriko SaegusaHaruaki Nakaya
May 28, 2008·Pflügers Archiv : European journal of physiology·Anders Peter LarsenThomas Jespersen
Nov 11, 2008·Pflügers Archiv : European journal of physiology·Andreas FeigenspanReto Weiler
Jun 15, 2010·Pflügers Archiv : European journal of physiology·Michael C Sanguinetti
Jan 20, 2004·European Journal of Pharmacology·Martin TraebertWilli Suter
Jan 22, 2004·Journal of Molecular and Cellular Cardiology·Zhi SuGary Gintant
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Martin Tristani-Firouzi, Michael C Sanguinetti
Dec 20, 2003·Progress in Cardiovascular Diseases·Ian W GlaaserColleen E Clancy
Dec 15, 2011·Expert Reviews in Molecular Medicine·Jodene Eldstrom, David Fedida
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hongkang ZhangMin Li
Oct 18, 2006·Clinical and Experimental Pharmacology & Physiology·James T LimberisRuth L Martin
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Colleen E ClancyRobert S Kass
Sep 27, 2007·PloS One·Sung Yon Um, Thomas V McDonald
May 1, 2006·Future Cardiology·Mark J McPateJules C Hancox
May 23, 2014·European Journal of Pharmacology·Yan LongZhiyuan Li
Dec 22, 2007·The Journal of Physiology·Glenna C L Bett, Randall L Rasmusson
Jan 15, 2014·Journal of Pharmacological and Toxicological Methods·Aldo A Rodriguez-MenchacaEloy G Moreno-Galindo
Oct 8, 2013·Current Problems in Cardiology·John R Giudicessi, Michael J Ackerman
Oct 30, 2012·Journal of Pharmacological and Toxicological Methods·Daniel J GillieClaire Townsend
Apr 20, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Joachim R Ehrlich
Aug 18, 2009·Journal of Molecular and Cellular Cardiology·Flavien CharpentierIsabelle Baró
Jul 12, 2008·Pharmacology & Therapeutics·Jules C HancoxYi Hong Zhang
Mar 26, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Morten Grunnet
Aug 11, 2007·Critical Reviews in Oncology/hematology·Caroline AméenPeter Sartipy
Dec 23, 2006·Journal of Molecular and Cellular Cardiology·Robert Dumaine, Jonathan M Cordeiro
May 19, 2004·British Journal of Pharmacology·Dierk ThomasJohann Kiehn
Jul 28, 2004·British Journal of Pharmacology·Gernot SchramStanley Nattel
Jun 8, 2012·Chirality·Carmen ValenzuelaTeresa González
Apr 22, 2010·Cardiovascular Therapeutics·Harry J Witchel
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Ganga KrishnamurthyMichael R Rosen
Nov 6, 2004·Neuropharmacology·Zoe A McCrossan, Geoffrey W Abbott
Sep 24, 2004·Journal of Pharmacological and Toxicological Methods·Glenn E KirschArthur M Brown
Jun 11, 2004·European Journal of Pharmacology·Kenji TsujimaeYoshihisa Kurachi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.